Molecular pharmacology of somatostatin receptor subtypes

Overview of attention for article published in Journal of Endocrinological Investigation, April 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

patent: 7 patents

Citations

dimensions_citation: 253 Dimensions

Readers on

mendeley: 30 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

Tetrahydronaphthyridine somatostatin receptor 5 antagonists

Grant US-9751878-B2

United States of America

Spiro azetidine isoxazole derivatives and their use as SSTR antagonists

Grant US-9605000-B2

United States of America

Tetrahydronaphthyridine somatostatin receptor 5 antagonists

Grant US-9353108-B2

United States of America

Heterocyclic compound

Grant US-9120777-B2

United States of America

ANTAGONISTS OF SOMATOSTATIN RECEPTOR SUBTYPE 5 (SSTR5)

Application WO-2015052910-A1

World Intellectual Property Organisation (WIPO)

SPIRO AZETIDINE ISOXAZOLE DERIVATIVES AND THEIR USE AS SSTR5 ANTAGONISTS

Application WO-2014142363-A1

World Intellectual Property Organisation (WIPO)

A METHOD FOR THE PREVENTION OF A PATIENT'S FIBROPROLIFERATIVE VASCULOPATHY

Application WO-1999049884-A1

World Intellectual Property Organisation (WIPO)